Foghorn Therapeutics Inc.FHTXNASDAQ
Loading
Research and development spending
3Y CAGR
-6.8%/yr
vs +49.4%/yr prior
5Y CAGR
+8.2%/yr
Recent deceleration
Acceleration
-56.2pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $85.47M | -9.6% |
| 2024 | $94.53M | -13.8% |
| 2023 | $109.69M | +3.9% |
| 2022 | $105.62M | +31.5% |
| 2021 | $80.33M | +39.2% |
| 2020 | $57.72M | +30.1% |
| 2019 | $44.36M | +109.0% |
| 2018 | $21.23M | - |